Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?
✍ Scribed by Joseph Kattan; Stéphane Culine; Tahereh Tavakoli-Razavi; Andrew Kramar; Jean-Pierre Droz
- Publisher
- Springer-Verlag
- Year
- 1994
- Tongue
- English
- Weight
- 360 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. VAB-5 represents an intensified version of the VAB-4 protocol. Poor prognostic features were considered to be bulky metastases (>5 cm in diameter), palpab
Twenty-seven patients with metastatic nonseminomatous germ cell tumors were treated with Cisplatin, vinblastine, bleomycin, and low-dose methotrexate (PVB + M) combinations. Patients were divided into good-risk and poor-risk groups. All seven patients (100%) with good-risk factors achieved complete
The allocation of patients with advanced germ cell tumors (GCT) to different treatment programs based on clinical characteristics is standard in the design of clinical trials today. Studies have shown that substantial differences exist between entry criteria and that these differences could influenc